Grifols SA (Grifols) is a pharmaceutical and chemical manufacturer that focuses on enhancing the health and well-being of people around the world. It conducts research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. It produces plasma derived protein therapies for patients suffering with rare, chronic and life-threatening infections. Grifols offers biological materials for clinical trials, biotechnology research, manufacturing pharmaceutical and diagnostic products. Grifols provides transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. The company offers its products to hospitals, pharmacies and healthcare professionals. It offers products in the US, Canada, Europe, and Rest of the world. Grifols is headquartered in Barcelona, Spain.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Grifols SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Grifols SA Company Overview
- Grifols SA Company Snapshot
- Grifols SA Pipeline Products and Ongoing Clinical Trials Overview
- Grifols SA - Pipeline Analysis Overview
- Business Description
- Grifols SA - Key Facts
- Grifols SA - Major Products and Services
- Grifols SA Pipeline Products by Development Stage
- Grifols SA Pipeline Products Overview
- AKST1210
- AKST1210 Product Overview
- Diagnostic Test - Autoimmunity
- Diagnostic Test - Autoimmunity Product Overview
- Diagnostic Test - Cardiovascular Diseases
- Diagnostic Test - Cardiovascular Diseases Product Overview
- Diagnostic Test - Central Nervous System
- Diagnostic Test - Central Nervous System Product Overview
- Diagnostic Test - Oncology
- Diagnostic Test - Oncology Product Overview
- Extended Blood Typing Reagent
- Extended Blood Typing Reagent Product Overview
- FIBROchip
- FIBROchip Product Overview
- GigaMune HemeOnc
- GigaMune HemeOnc Product Overview
- Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human
- Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human Product Overview
- Hemostasis Reagent Kit - DG-Latex D Dimer
- Hemostasis Reagent Kit - DG-Latex D Dimer Product Overview
- Hemostasis Reagent Kit - DG-Latex VWF: Gp1b
- Hemostasis Reagent Kit - DG-Latex VWF: Gp1b Product Overview
- Hemostasis Reagent Kit - DG-TT L Human
- Hemostasis Reagent Kit - DG-TT L Human Product Overview
- IH Blood Genotyping (D) Kit
- IH Blood Genotyping (D) Kit Product Overview
- mAbs Reagent - Dengue
- mAbs Reagent - Dengue Product Overview
- Mabs Reagent - Ebola Virus
- Mabs Reagent - Ebola Virus Product Overview
- mAbs Reagent - HBV Infection
- mAbs Reagent - HBV Infection Product Overview
- mAbs Reagent - HCV Infection
- mAbs Reagent - HCV Infection Product Overview
- mAbs Reagent - HIV Infection
- mAbs Reagent - HIV Infection Product Overview
- mAbs Reagent - HTLV Infection
- mAbs Reagent - HTLV Infection Product Overview
- mAbs Reagent - Thrombosis
- mAbs Reagent - Thrombosis Product Overview
- mAbs Reagent - Zika Virus
- mAbs Reagent - Zika Virus Product Overview
- Promonitor - Autoimmune And Inflammation
- Promonitor - Autoimmune And Inflammation Product Overview
- Sgx Clarity cTnl Assay
- Sgx Clarity cTnl Assay Product Overview
- Sgx Clarity System Sepsis Rule-Out / Rule-In Test
- Sgx Clarity System Sepsis Rule-Out / Rule-In Test Product Overview
- Sgx Clarity System - SIRS Rule-Out / Rule-In Test
- Sgx Clarity System - SIRS Rule-Out / Rule-In Test Product Overview
- Singulex POC System
- Singulex POC System Product Overview
- SMC Adiponectin Test
- SMC Adiponectin Test Product Overview
- SMC Endothelin Assay
- SMC Endothelin Assay Product Overview
- SMC HDL With Fractionation Assay
- SMC HDL With Fractionation Assay Product Overview
- SMC HDL2b Test
- SMC HDL2b Test Product Overview
- SMC IL-10 Assay
- SMC IL-10 Assay Product Overview
- SMC IL-17A Assay
- SMC IL-17A Assay Product Overview
- SMC IL-6 Assay
- SMC IL-6 Assay Product Overview
- SMC Leptin Test
- SMC Leptin Test Product Overview
- SMC sdLDL Assay
- SMC sdLDL Assay Product Overview
- SMC TNF-Alpha Assay
- SMC TNF-Alpha Assay Product Overview
- Grifols SA - Key Competitors
- Grifols SA - Key Employees
- Grifols SA - Key Employee Biographies
- Grifols SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- HemaCare Corp
- CSL Ltd
- Takeda Pharmaceutical Co Ltd
- Oryzon Genomics SA
- Abeona Therapeutics Inc
- Omnicell Inc
- AB-Biotics SA